Madison Square Garden ENT

Forecast & Rating9 analysts currently cover Madison Square Garden ENT, with about 44.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $80.71, about 4.4% upside from the current price of $77.32. Price targets are fairly clustered, pointing to relatively aligned views. Historically, about 98.5% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Madison Square Garden ENT are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 21, 2026; for reference only and not investment advice.